Re: Another Exempt Distribution - 2021-04-15
|
|
Resverlogix Corp.
|
Apr 17, 2021 02:02PM
|
Re: Another Exempt Distribution - 2021-04-15
|
|
Resverlogix Corp.
|
Apr 17, 2021 01:25PM
|
Binary
|
8
|
Resverlogix Corp.
|
Apr 15, 2021 04:27PM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
1
|
Resverlogix Corp.
|
Apr 15, 2021 04:24PM
|
Re NR
|
8
|
Resverlogix Corp.
|
Apr 14, 2021 02:33PM
|
Finance
|
1
|
Resverlogix Corp.
|
Apr 13, 2021 09:30AM
|
Volume
|
2
|
Zenith Epigenetics
|
Apr 13, 2021 08:38AM
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
7
|
Resverlogix Corp.
|
Apr 12, 2021 02:04PM
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 01:56PM
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 11:21AM
|
Re: K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 09:54AM
|
K2
|
2
|
Resverlogix Corp.
|
Apr 10, 2021 08:39AM
|
Re: This late June meeting, warrants about to expire???
|
3
|
Resverlogix Corp.
|
Apr 09, 2021 04:27PM
|
Re: This late June meeting, warrants about to expire???
|
1
|
Resverlogix Corp.
|
Apr 09, 2021 03:43PM
|
Re: This late June meeting, warrants about to expire???
|
1
|
Resverlogix Corp.
|
Apr 09, 2021 11:56AM
|
Re: Saudi
|
1
|
Resverlogix Corp.
|
Apr 07, 2021 03:28PM
|
Re: Saudi
|
4
|
Resverlogix Corp.
|
Apr 07, 2021 09:54AM
|
Re: Management
|
3
|
Resverlogix Corp.
|
Apr 05, 2021 08:32AM
|
Re: Year-end financials
|
2
|
Resverlogix Corp.
|
Apr 01, 2021 02:32PM
|
Re: Biotech Valuation
|
8
|
Resverlogix Corp.
|
Mar 31, 2021 11:14AM
|